Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial-Reference-Cited by-同舟云学术

Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial

Published:2022-06-20 Issue:4 Volume:30 Page:1277-1282
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Moslemi Mohammadreza,Hejazian Seyyedeh Mina,Shaddelan Molod,Javanali Fatemeh,Mirghaffari Alireza,Sadeghi Armin,Valizadeh Hamed,Sharifi Akbar,Haramshahi Morteza,Ardalan Mohammadreza^ORCID,Zununi Vahed Sepideh

Funder

Tabriz University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

https://link.springer.com/content/pdf/10.1007/s10787-022-01001-2.pdf

Reference21 articles.

1. Abouhashem AS, Singh K, Azzazy HME, Sen CK (2020) Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19? Antioxid Redox Signal 33:59–65. https://doi.org/10.1089/ars.2020.8111

2. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM et al (1996) Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 93:2448–2453. https://doi.org/10.1073/pnas.93.6.2448

3. de Alencar JCG, de Moreira CL,Müller AD, Chaves CE, Fukuhara MA, da Silva EA, de Miyamoto MFS, Pinto VB, Bueno CG, Neto FL, Gomez LMG, Menezes MCS, Marchini JFM, Marino LO, Brandão Neto RA, Souza HP, (2021) (2020) Double-blind Randomized Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19). Clin Infect Dis 72(11) e736–e741. https://doi.org/10.1093/cid/ciaa1443

4. Dikalov SI, Nazarewicz RR (2013) Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease. Antioxid Redox Signal 19:1085–1094. https://doi.org/10.1089/ars.2012.4604

5. Ibrahim H, Perl A, Smith D, Lewis T, Kon Z, Goldenberg R, Yarta K, Staniloae C, Williams M (2020) Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine. Clin Immunol 219108544. https://doi.org/10.1016/j.clim.2020.108544

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Edaravone: A Possible Treatment for Acute Lung Injury;International Journal of General Medicine;2024-09

2. Effectiveness of edaravone in preventing contrast‐induced nephropathy in high‐risk patients undergoing coronary angiography: A randomized, double‐blind trial;Pharmacology Research & Perspectives;2024-07-02

3. New and little-known possibilities of edaravone in the treatment of cerebral stroke and extracranial pathology;Infusion & Chemotherapy;2023-09-29

4. The effect of Fingolimod on patients with moderate to severe COVID ‐19;Pharmacology Research & Perspectives;2022-12-25